HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acquired amegakaryocytic thrombocytopenia

Severe thrombocytopenia and selective, marked decrease or absence of megakaryocytes
Networked: 20 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Pure Red-Cell Aplasia
2. Thymoma (Thymic Carcinoma)
3. Adult-Onset Still's Disease
4. Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
5. Thrombocytosis (Thrombocythemia)

Experts

1. Gu, Chengyuan: 1 article (08/2022)
2. Kong, Danqing: 1 article (08/2022)
3. Li, Yun: 1 article (08/2022)
4. Tian, Hong: 1 article (08/2022)
5. Wang, Zhaoyue: 1 article (08/2022)
6. Wu, Depei: 1 article (08/2022)
7. Yin, Jie: 1 article (08/2022)
8. Yu, Ziqiang: 1 article (08/2022)
9. Al-Samkari, Hanny: 1 article (01/2022)
10. Park, Albert K: 1 article (01/2022)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Acquired amegakaryocytic thrombocytopenia:
1. Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
2. Cyclosporine (Ciclosporin)FDA LinkGeneric
3. Inosine Triphosphate (ITP)IBA
4. AutoantibodiesIBA
5. eltrombopagFDA Link
6. Thrombopoietin ReceptorsIBA
7. Intravenous Immunoglobulins (IVIG)FDA Link
8. gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA
9. Thrombopoietin (c-mpl Ligand)IBA
10. SteroidsIBA

Therapies and Procedures

1. Thymectomy
2. Stem Cell Transplantation
3. Therapeutics
4. Radiotherapy
5. Drug Therapy (Chemotherapy)